IIQ 6.25% 59.5¢ inoviq ltd

Ann: Update on Legal Proceedings and BARD1 Autoantibody Program, page-31

  1. 971 Posts.
    lightbulb Created with Sketch. 1499
    where is the scheduled release for feasibility studies of both the Breast Cancer and Ovarian Cancer detection? it was clearly presented that these reports will be released by Q1 2022, which is today.
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.